NovalGen is a pioneering immunotherapy company specializing in the development of next-generation multi-specific antibody therapies. The company's innovative approaches aim to enhance treatment efficacy in various diseases, positioning NovalGen at the forefront of biotechnology and pharmaceuticals within the life sciences industry.
Specialties
Multi-specific antibody therapies
Innovative immunotherapy solutions
Next-generation treatment approaches
Collaborative academic partnerships
Disease efficacy enhancement
Products & Services
Multi-specific antibody therapies
Immunotherapy solutions
Disease-specific treatments
Biomedical research collaborations
Clinical trial support services
Contact Information
No contact information available
Competitors & Similar Companies(9)
Amgen
California, • United States
Genentech
California, • United States
Bristol-Myers Squibb
New York, • United States
Regeneron Pharmaceuticals
New York, • United States
AstraZeneca
Greater London, • United Kingdom
Gilead Sciences
California, • United States
Moderna
Massachusetts, • United States
Roche
Basel-City, • Switzerland
UCB
Brussels Hoofdstedelijk Gewest, • Belgium
News & Media
Search Terms:
novalgen
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about NovalGen
Where is NovalGen located?
The headquarter of NovalGen is located in Northwood, England, United Kingdom
What products and services is NovalGen likely to offer?
NovalGen offers Multi-specific antibody therapies, Immunotherapy solutions, Disease-specific treatments, Biomedical research collaborations, Clinical trial support services.
Who are the competitors of NovalGen?
Competitors of NovalGen are Amgen, Genentech, Bristol-Myers Squibb, Regeneron Pharmaceuticals, AstraZeneca, Gilead Sciences, Moderna, Roche, UCB.
What does NovalGen do?
NovalGen is a pioneering immunotherapy company specializing in the development of next-generation multi-specific antibody therapies. The company's innovative approaches aim to enhance treatment efficacy in various diseases, positioning NovalGen at the forefront of biotechnology and pharmaceuticals within the life sciences industry.